Future Treatment Outlook for Rare Dermatological Disorders

Author(s):

Boni Elewski, MD, and Benjamin Kaffenberger, MD, and Carly Elston, MD, provide their clinical recommendations regarding future treatments for rare dermatological disorders.

EP: 1.Prevalence of Rare Dermatological Disorders

EP: 2.Symptoms of Rare Dermatological Disorders

EP: 3.Pathophysiology of GPP, PPP, and SJS

EP: 4.GPP, PPP and SJS: Typical Patient Journey

EP: 5.Diagnosis of Rare Dermatological Disorders

EP: 6.Differential Diagnosis of Rare Skin Conditions

EP: 7.Challenges in Managing Rare Skin Conditions

EP: 8.Initial Management Of Patients With Rare Dermatological Disorders

EP: 9.Use of Biologics in Rare Dermatologic Disorders

EP: 10.Spesolimab for Treatment of GPP

Now Viewing

Future Treatment Outlook for Rare Dermatological Disorders

EP: 1.Prevalence of Rare Dermatological Disorders

EP: 2.Symptoms of Rare Dermatological Disorders

EP: 3.Pathophysiology of GPP, PPP, and SJS

EP: 4.GPP, PPP and SJS: Typical Patient Journey

EP: 5.Diagnosis of Rare Dermatological Disorders

EP: 6.Differential Diagnosis of Rare Skin Conditions

EP: 7.Challenges in Managing Rare Skin Conditions

EP: 8.Initial Management Of Patients With Rare Dermatological Disorders

EP: 9.Use of Biologics in Rare Dermatologic Disorders

EP: 10.Spesolimab for Treatment of GPP

EP: 11.Future Treatment Outlook for Rare Dermatological Disorders

EP: 12.Improving Recognition and Referral of Rare Conditions in Rare Setting

EP: 13.Patient Subgroups and Educational Opportunities in Rare Dermatological Disorders

EP: 14.Recommendations for Management of Rare Dermatological Disorders in Critical Care Setting